Federal contract award
W15QKN24C0056
PRECISION TARGETING BASE PLUS TWO OPTION YEARS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W6QK ACC-RI-PICATINNY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AC13 — NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $7.3M |
| Current contract value | $7.3M |
| Potential contract value / ceiling | $7.3M |
| Start date | Aug 21, 2024 |
| Current end date | Jun 21, 2027 |
| Potential end date | Jun 21, 2027 |
| Latest award activity | May 22, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 18 of 18 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 22, 2026 | P00010 | $0 | CHANGE PAY OFFICE |
| May 19, 2026 | P00009 | $1.1M | INCREMENTAL FUNDING - OPTION YEAR 1 |
| Apr 16, 2026 | P00008 | $585.5K | EXERCISE OPTION YEAR 1. CLARIFY FULL SCOPE OF REQUIREMENT. |
| Apr 16, 2026 | P00008 | $585.5K | EXERCISE OPTION YEAR 1. CLARIFY FULL SCOPE OF REQUIREMENT. |
| Mar 10, 2026 | P00007 | $0 | NO COST EXTENSION |
| Mar 10, 2026 | P00007 | $0 | NO COST EXTENSION |
| Sep 18, 2025 | P00006 | $0 | DEOBLIGATE MODIFICATION. |
| Sep 18, 2025 | P00006 | $0 | DEOBLIGATE MODIFICATION. |
| Aug 20, 2025 | P00005 | $0 | EXTEND PERIOD OF PERFORMANCE 6 MONTHS |
| Aug 20, 2025 | P00005 | $0 | EXTEND PERIOD OF PERFORMANCE 6 MONTHS |
| Mar 13, 2025 | P00004 | $566.5K | INCREMENTAL FUNDED CLIN 0001. |
| Mar 13, 2025 | P00004 | $566.5K | INCREMENTAL FUNDED CLIN 0001. |
| Feb 11, 2025 | P00003 | $346.6K | INCREMENTAL FUNDING FOR CLIN 0001, SUBCLIN 00110. |
| Feb 11, 2025 | P00003 | $346.6K | INCREMENTAL FUNDING FOR CLIN 0001, SUBCLIN 00110. |
| Dec 6, 2024 | P00002 | $51.0K | INCREMENTAL FUNDING P00002, SUBCLIN 000109. |
| Dec 6, 2024 | P00002 | $51.0K | INCREMENTAL FUNDING P00002, SUBCLIN 000109. |
| Sep 24, 2024 | P00001 | $650.0K | INCREMENTALLY FUND CLIN 0001 UNDER SUBCLIN 000108. |
| Aug 21, 2024 | 0 | $3.5M | PRECISION TARGETING BASE PLUS TWO OPTION YEARS. |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
70/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 70/100. Available recorded signals: 65 points.
- Contract end 2027-06-21 (232 days from calculation)
- +35 points
- 8 historical awards in this buyer and category group
- +15 points
- 18 recorded award transactions
- +10 points
- Latest award action: 2026-05-22
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.